EDITORIAL
Published on 09 Dec 2025
Editorial: Bispecific antibodies and their conjugates in solid tumors and hematological malignancies
doi 10.3389/fimmu.2025.1752360
- 260 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Bispecific Antibodies and their Conjugates in Solid Tumors and Hematological Malignancies
Bispecific Antibodies and their Conjugates in Solid Tumors and Hematological Malignancies
7,495
Total downloads
45k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 18 Sep 2025
Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter cohort study
doi 10.3389/fimmu.2025.1607138
- 2,065 views
SYSTEMATIC REVIEW
Published on 10 Sep 2025
Dual-target immunotherapies in NSCLC: a systematic review and meta-analysis of randomized clinical trials
doi 10.3389/fimmu.2025.1605877
- 2,878 views
ORIGINAL RESEARCH
Published on 27 Aug 2025
Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3
doi 10.3389/fimmu.2025.1642454
- 2,670 views
ORIGINAL RESEARCH
Published on 12 Aug 2025
Dual T/NK cell engagement via B7-H6-targeted bispecific antibodies and IL-15 eradicates chemo-resistant solid tumors
doi 10.3389/fimmu.2025.1625813
- 2,517 views
REVIEW
Published on 23 Jul 2025
Blinatumomab in pediatric B-acute lymphoblastic leukemia
doi 10.3389/fimmu.2025.1611701
- 4,177 views
CORRECTION
Published on 17 Jul 2025
Correction: Bispecific antibody for lung cancer: mechanisms and clinical insights
doi 10.3389/fimmu.2025.1656082
- 676 views
ORIGINAL RESEARCH
Published on 18 Jun 2025
Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA
doi 10.3389/fimmu.2025.1612547
- 6,948 views
- 2 citations
REVIEW
Published on 29 May 2025
Bispecific antibody for lung cancer: mechanisms and clinical insights
doi 10.3389/fimmu.2025.1572802
- 5,868 views
- 1 citation
SYSTEMATIC REVIEW
Published on 25 Apr 2025
Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1565407
- 5,783 views
- 1 citation
MINI REVIEW
Published on 09 Apr 2025
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024
doi 10.3389/fonc.2025.1566202
- 3,008 views
- 2 citations
CASE REPORT
Published on 31 Mar 2025
Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report
doi 10.3389/fimmu.2025.1566035
- 3,000 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore